Patents Assigned to Shanghai Institute of Material Medica, Chinese Academy of Sciences
  • Patent number: 11655239
    Abstract: The present disclosure relates to a fused ring pyrimidine amino compound and a preparation method, a pharmaceutical composition, and a use thereof. Specifically disclosed in the present disclosure are the compound shown in formula I, a pharmaceutically acceptable salt thereof, a tautomer thereof, a stereoisomer thereof, a metabolite thereof, a metabolic precursor thereof, or a prodrug thereof. The fused ring pyrimidine amino compound of the present application has good inhibitory activity against DDRs, particularly DDR2, and has a good therapeutic effect on tumors and fibrotic diseases, especially pulmonary inflammation and pulmonary fibrosis. Also disclosed in the present disclosure are a preparation method for the compound shown in formula I, and a use thereof.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: May 23, 2023
    Assignee: Shanghai Institute Of Material Medica, Chinese Academy of Sciences
    Inventors: Bing Xiong, Jia Li, Meiyu Geng, Jingkang Shen, Yi Zang, Jing Ai, Danqi Chen, Qi Wang, Ying Dong, Xia Peng, Yinchun Ji, Qian Tan
  • Publication number: 20190055565
    Abstract: Provided are a dsRNA construct of an orphan G-protein-coupled receptor GPR160 gene related to prostate cancer and the use thereof, wherein the dsRNA construct of the GPR160 gene and a composition thereof can prevent or treat prostate cancer.
    Type: Application
    Filed: September 29, 2016
    Publication date: February 21, 2019
    Applicant: Shanghai Institute of Material Medica, Chinese Academy of Sciences
    Inventors: Caihong Zhou, Xinchuan Dai, Mingwei Wang